Active Research Protocols
- 13-M-0004 – The Use of Daily, Intranasal Oxytocin for the Treatment of Childhood-Onset Schizophrenia (COS), a Randomized Double-Blind Trial
- 97-M-0126 – Childhood Onset Psychotic Disorders: Characterization and Treatment with Atypical Neuroleptics
NOTE: PDF documents require the freeAdobe Reader.
This page was last updated: January 24, 2014